Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude mice
- PMID: 16973228
- DOI: 10.1016/j.radonc.2006.08.012
Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude mice
Abstract
Background and purpose: The present study was performed to test the hypothesis that lactate accumulation correlates with the radioresistance of malignant tumors due to the radical scavenging capacity of lactate or metabolic intermediates of glycolysis, such as pyruvate.
Materials and methods: Five human head and neck squamous cell carcinoma cell lines (HNSCCs) xenografted in nude mice were treated with a clinically relevant irradiation protocol with 30 fractions within 6 weeks. The radiation dose necessary to locally control 50% of the tumors (TCD50) ranged from 47.4 to 129.8 Gy. Concentrations of glucose, lactate, and ATP in viable tumor regions as potential indicators of glycolytic activity were assessed with structure-associated quantitative bioluminescence imaging.
Results: Mean lactate concentrations of the different tumor cell lines were in the range of 7.3-25.9 micromol/g. TCD50 values were positively correlated with tumor lactate levels (R = 0.9824, p = 0.0028).
Conclusions: The data obtained support the hypothesis that tissue lactate content correlates with radioresistance in solid human tumors. Furthermore, the results suggest that tumor lactate content determined non-invasively by proton magnetic resonance spectroscopy imaging may be used to predict for radioresistance of malignancies in the clinic; the data also imply that transient inhibition of glycolysis during treatment might possibly sensitize tumors to irradiation.
Comment in
-
Tumour hypoxia - a characteristic feature with a complex molecular background.Radiother Oncol. 2006 Nov;81(2):119-21. doi: 10.1016/j.radonc.2006.09.005. Epub 2006 Oct 16. Radiother Oncol. 2006. PMID: 17050018 No abstract available.
Similar articles
-
Glycolytic metabolism and tumour response to fractionated irradiation.Radiother Oncol. 2010 Jan;94(1):102-9. doi: 10.1016/j.radonc.2009.11.007. Epub 2009 Dec 28. Radiother Oncol. 2010. PMID: 20036432
-
Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies.Radiother Oncol. 2006 Nov;81(2):122-9. doi: 10.1016/j.radonc.2006.08.010. Epub 2006 Sep 7. Radiother Oncol. 2006. PMID: 16956683
-
Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation.Radiother Oncol. 2007 Jun;83(3):304-10. doi: 10.1016/j.radonc.2007.04.020. Epub 2007 May 22. Radiother Oncol. 2007. PMID: 17517444
-
Lactate: mirror and motor of tumor malignancy.Semin Radiat Oncol. 2004 Jul;14(3):267-74. doi: 10.1016/j.semradonc.2004.04.004. Semin Radiat Oncol. 2004. PMID: 15254870 Review.
-
Lactate: a metabolic key player in cancer.Cancer Res. 2011 Nov 15;71(22):6921-5. doi: 10.1158/0008-5472.CAN-11-1457. Cancer Res. 2011. PMID: 22084445 Review.
Cited by
-
Effects of three modifiers of glycolysis on ATP, lactate, hypoxia, and growth in human tumor cell lines in vivo.Strahlenther Onkol. 2012 May;188(5):431-7. doi: 10.1007/s00066-011-0054-3. Epub 2012 Feb 16. Strahlenther Onkol. 2012. PMID: 22349632
-
Molecular mechanisms of long noncoding RNAs associated with cervical cancer radiosensitivity.Front Genet. 2023 Jan 4;13:1093549. doi: 10.3389/fgene.2022.1093549. eCollection 2022. Front Genet. 2023. PMID: 36685972 Free PMC article. Review.
-
Transmembrane Protease TMPRSS11B Promotes Lung Cancer Growth by Enhancing Lactate Export and Glycolytic Metabolism.Cell Rep. 2018 Nov 20;25(8):2223-2233.e6. doi: 10.1016/j.celrep.2018.10.100. Cell Rep. 2018. PMID: 30463017 Free PMC article.
-
Novel insight into metabolic reprogrammming in cancer radioresistance: A promising therapeutic target in radiotherapy.Int J Biol Sci. 2023 Jan 1;19(3):811-828. doi: 10.7150/ijbs.79928. eCollection 2023. Int J Biol Sci. 2023. PMID: 36778122 Free PMC article. Review.
-
Immunologic and metabolic characteristics of HPV-negative and HPV-positive head and neck squamous cell carcinomas are strikingly different.Virchows Arch. 2014 Sep;465(3):299-312. doi: 10.1007/s00428-014-1630-6. Epub 2014 Jul 16. Virchows Arch. 2014. PMID: 25027580
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical